In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Synphora AB

Latest From Synphora AB

Otonomy raises $38.5 million to advance Meniere's disease treatment

Otonomy, a private US biopharmaceutical company focused on disorders of the inner and middle ear, has raised $38.5 million in a series B round.

Orthopedics Companies

Deals Shaping the Medical Industry (11/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Synphora AB
  • Senior Management
  • Irene Aspman, CEO
    Johan Stjernschantz, VP, R&D
  • Contact Info
  • Synphora AB
    Phone: (46) 18 5120 76
    Uppsala Science Park
    Uppsala, S-751